GF Fund Management’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.5K Hold
1,751
﹤0.01% 646
2025
Q1
$2.8K Buy
1,751
+269
+18% +$430 ﹤0.01% 644
2024
Q4
$5.34K Buy
+1,482
New +$5.34K ﹤0.01% 609